36 Gordon Square
London WC1H 0PD

T +44 (0) 20 7958 8251
admin@lidc.bloomsbury.ac.uk

Neglected disease research and development : is innovation under threat?

Thursday, December 8, 2011 - 10:30 to 12:00

Global lunch of the G-FINDER Report, London
Time: 10.30am - 12.30pm,

London, Academy of Medical Sciences, John Newsom-Davis CR/CC
Speakers: Dr Javier Guzman, Policy Cures; UK Department for International Development; sanofi-aventis; Bill & Melinda Gates Foundation; Tuberculosis Vaccine Initiative (TBVI)
Chair: Andrew Jack, Financial Times
The fourth annual G-FINDER report reveals that the global financial crisis has hit neglected disease R&D funding for the first time in 2010. As the purse strings are tightened, will R&D of innovative new products for global health come under threat? Join the report co-author, Dr Javier Guzman, and key commentators to discuss the report's findings and what this means for the future.
G-FINDER survey is the most comprehensive report to date on public and private funding into R&D for neglected diseases like malaria, TB, HIV, pneumonia, sleeping sickness and helminth infections. It covers 31 diseases and 134 product areas. G-FINDER is conducted by the independent research group Policy Cures and funded by the Bill & Melinda Gates Foundation.
More: